TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA

被引：0

作者：

Tabatabai, G. ^{[1
]}

von Baumgarten, L. ^{[2
]}

van den Bent, M. ^{[3
]}

Burger, M. C. ^{[4
,5
]}

Freres, P. ^{[6
]}

Glas, M. ^{[7
]}

Hau, P. ^{[8
]}

Herrlinger, U. ^{[9
]}

Mildenberger, I. ^{[10
]}

Neyns, B. ^{[11
]}

Schaefer, H. ^{[12
]}

Seidel, C. ^{[13
]}

de Vos, F. ^{[14
]}

Galot, R. ^{[15
]}

Whenham, N. ^{[15
]}

Wick, A. ^{[16
]}

Falk, M. ^{[17
]}

Chama, L. de Freitas ^{[18
]}

Henze, J. ^{[17
]}

Kelemen, P. ^{[17
]}

Koch, S. D. ^{[18
]}

Lutz, J. ^{[18
]}

Heidenreich, R. ^{[18
]}

Roche, P. Romer ^{[17
]}

Rost, T. ^{[17
]}

Schoenborn-Kellenberger, O. ^{[17
]}

Gnad-Vogt, U. ^{[17
]}

机构：

[1] Tubingen Univ Hosp, Tubingen, Germany

[2] Ludwig Maximilians Univ Munchen, Neurosurg Clin & Polyclin, Munich, Germany

[3] Erasmus MC Canc Inst, Rotterdam, Netherlands

[4] Goethe Univ Hosp, Frankfurt, Germany

[5] Hosp Frankfurt, Ctr Neurologsurg & Neurooncol, Frankfurt, Germany

[6] Liege Univ Hosp, Frankfurt, Germany

[7] Univ Med Essen, Essen, Germany

[8] Univ Hosp Regensburg, Regensburg, Germany

[9] Univ Bonn, Bonn, Germany

[10] Mannheim Univ, Med Ctr, Mannheim, Germany

[11] Univ Hosp Brussels, Brussels, Belgium

[12] Univ Freiburg, Freiburg, Germany

[13] Univ Hosp Leipzig, Frankfurt, Germany

[14] Univ Med Ctr Utrecht, Frankfurt, Germany

[15] Univ St Luc Hosp, Brussels, Belgium

[16] Heidelberg Univ Hosp, Heidelberg, Germany

[17] CureVac SE, Wiesbaden, Germany

[18] CureVac SE, Tubingen, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P06.09.B

引用

页码：47 / 47

页数：1

共 50 条

[41] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
Wei, Kuo-Chen
Hsu, Peng-Wei
Tsai, Hong-Chieh
Lin, Ya-Jui
Chen, Ko-Ting
Toh, Cheng-Hong
Huang, Hui-Lin
Jung, Shih-Ming
Tseng, Chen-Kan
Ke, Yu-Xiong
SCIENTIFIC REPORTS, 2021, 11 (01)
[42] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
Kuo-Chen Wei
Peng-Wei Hsu
Hong-Chieh Tsai
Ya-Jui Lin
Ko-Ting Chen
Cheng-Hong Toh
Hui-Lin Huang
Shih-Ming Jung
Chen-Kan Tseng
Yu-Xiong Ke
Scientific Reports, 11
[43] A Randomized Controlled Phase 2 Dose-Finding Trial to Evaluate the Efficacy and Safety of Camostat in the Treatment of Painful Chronic Pancreatitis: The TACTIC Study
Hart, Phil A.
Osypchuk, Yurii
Hovbakh, Iryna
Shah, Raj J.
Nieto, Jose
Cote, Gregory A.
Avgaitis, Sergii
Kremzer, Oleksandr
Buxbaum, James
Inamdar, Sumant
Fass, Ronnie
Phillips, Raymond W.
Yadav, Dhiraj
Ladd, Antonio Mendoza
Al-Assi, M. Tarek
Gardner, Timothy
Conwell, Darwin L.
Irani, Shayna
Sheikh, Aasim
Nuttall, Janet
GASTROENTEROLOGY, 2024, 166 (04) : 658 - 666.e6
[44] Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours
Melissa L. Johnson
Judy S. Wang
Gerald Falchook
Carol Greenlees
Suzanne Jones
Donald Strickland
Giulia Fabbri
Caroline Kennedy
J. Elizabeth Pease
Liz Sainsbury
Alexander MacDonald
Stein Schalkwijk
Philip Szekeres
Jan Cosaert
Howard Burris
British Journal of Cancer, 2023, 128 : 1906 - 1915
[45] MULTI-CENTER, PHASE 2 STUDY EVALUATING THE PHARMACOKINETICS, SAFETY AND PRELIMINARY EFFICACY OF PAXALISIB IN NEWLY DIAGNOSED ADULT PATIENTS WITH UNMETHYLATED GLIOBLASTOMA (GBM)
Wen, Patrick Y.
de Groot, John
Battiste, James
Goldlust, Samuel
Damek, Denise
Ellingson, Benjamin
Garner, James
Friend, John
Simpson, Jeremy
Olivero, Alan
Cloughesy, Timothy
NEURO-ONCOLOGY, 2022, 24 : 76 - 77
[46] Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours
Johnson, Melissa L. L.
Wang, Judy S. S.
Falchook, Gerald
Greenlees, Carol
Jones, Suzanne
Strickland, Donald
Fabbri, Giulia
Kennedy, Caroline
Pease, J. Elizabeth
Sainsbury, Liz
MacDonald, Alexander
Schalkwijk, Stein
Szekeres, Philip
Cosaert, Jan
Burris, Howard
BRITISH JOURNAL OF CANCER, 2023, 128 (10) : 1906 - 1915
[47] REGORAFENIB IN COMBINATION WITH TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT-METHYLATED, IDH WILDTYPE GLIOBLASTOMA: A PHASE I DOSE-FINDING STUDY (REGOMA-2, EUDRA CT N° 2021-001604-15)
Padovan, M.
De Salvo, G.
Cerretti, G.
Krengli, M.
Caccese, M.
Maccari, M.
Farina, M.
Bergo, E.
Zabeo, C.
Grosso, D.
Caumo, F.
Coppola, M.
D'Avolio, A.
Zagonel, V.
Lombardi, G.
NEURO-ONCOLOGY, 2023, 25
[48] Trial in Progress: NOX66 in Combination with Palliative Radiotherapy in Patients with CRPC - A Phase 1 Safety and Dose Finding Study
Capp, Anne
Vocks, Isabell
Minns, Ian
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 33 - 33
[49] Safety and tolerability of oxaliplatin based pressurized intraperitoneal aerosol chemotherapy (PIPAC) for patients with peritoneal carcinomatosis: A phase I dose-finding study in Asian patients
Sundar, Raghav
Kim, Guo Wei
Tan, Hon Lyn
Wang, Lingzhi
Chue, Koy Min
Tai, Chia Hui
Teo, Siok Chin
Jang, Clarisse
Chee, Corissa
Lieske, Bettina
Chee, Cheng Ean
Shabbir, Asim
So, Jimmy Bok Yan
Yong, Wei-Peng
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[50] Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial
Derby, Sarah
Jackson, Mark R.
Williams, Karin
Stobo, Jamie
Kelly, Caroline
Sweeting, Lorna
Shad, Shumaila
Herbert, Christopher
Short, Susan C.
Williamson, Aoife
James, Allan
Nowicki, Stefan
Bulbeck, Helen
Chalmers, Anthony J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1371 - 1378

← 1 2 3 4 5 →